- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Distinguishing Sedation From Efficacy In Antipsychotic Treatment
This is a Virtual Event for PsychU members in Arizona; Las Vegas, Nevada; and San Diego, Imperial, Riverside and San Bernardino Counties, CA.
In this presentation, the objectives are to:
- Recognize the symptoms of acute agitation in an emergency department setting
- Understand the potential importance of minimizing sedation in the treatment of acute agitation in patients with schizophrenia
- Distinguish sedation from efficacy in antipsychotic treatment
- Understand the physiologic mechanisms for sedation and pharmacologic considerations when selecting an antipsychotic

Laura Brennan, PhD (OPDC)
Medical Science Liaison

John Awad, MD (OPDC)
Senior Medical Science Liaison
Speakers John Awad, MD, BPharm and Laura Brennan, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.